Effectiveness of Free and Liposome-Entrapped Antitumoral Drugs against Hepatocellular Carcinoma: A Comparative In vitro Study
Hepatocellular carcinoma (HCC) is a highly prevalent form of liver cancer. Sorafenib is the first-line treatment for patients who are not eligible for surgical procedures. Still, it causes important adverse effects, does not provide symptoms relief, and is marketed at expensive costs. Here we invest...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AMG Transcend Association
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher |